Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

UK academics are calling for targets for mental health research in order to meet the healthcare challenges of the next decade. Published today in Journal of Mental Health, researchers set out four overarching goals that will speed up implementation of mental health research and give a clear direction for researchers and funders to focus their efforts when it comes to better understanding the treatment of mental health.

Trees in the shape of two heads, one with green leaves in blue sky and the other with empty branches in grey sky.

The treatment of mental illness currently brings substantial costs to individuals, the NHS, and also to wider society. The need for innovation to promote good mental health has never been greater. In an effort to catalyse this innovation, researchers have set out four ambitious targets:

  1. Halve the number of children and young people experiencing persistent mental health problems
  2. Improve our understanding of the links between physical and mental health, and eliminate the mortality gap
  3. Increase the number of new and improved treatments, interventions and supports for mental health problems
  4. Improve the availability of choices and access to mental health care, treatment and support in hospital and community settings

The number of goals was limited to four in an effort to easily promote cross-sector partnerships, and to track their impacts.

Read the full story on the Department of Psychiatry website

Similar stories

Oxford vaccine reaches one billion doses released

The University of Oxford’s and our partners AstraZeneca have today announced that one billion doses of the ChAdOx1 nCov-19 coronavirus vaccine have been released, to more than 170 countries, marking a key milestone as part of the University and AstraZeneca’s joint vision to make the available to the world, on a not-for-profit basis for the world during the pandemic, and in perpetuity for low- and middle-income countries.

Research programme tackling COVID-19 variants of concern receives funding boost

A gift from the Red Avenue Foundation will enable the expansion of a major research programme aimed at rapidly identifying and interrogating emerging COVID-19 variants.

Phase I trial begins of new vaccine against the Plague

Researchers at the University of Oxford today launched a Phase 1 trial to test a new vaccine against plague.

New therapeutic targets identified in the treatment of psoriatic arthritis

Researchers identify two inflammatory-driving proteins, osteopontin and CCL2, highly expressed in psoriatic arthritis joints.

Treatment choice for rotator cuff disorders could create efficiency and savings for the NHS

A trial that evaluated the clinical and cost effectiveness of physiotherapy treatments for rotator cuff disorders suggests cost savings can be made while maintaining positive patient outcomes.